NCT00676728 2012-09-14A Study of the Histone-deacetylase Inhibitor JNJ-26481585 in Patients With Advanced or Refractory Leukemia or Myelodysplastic SyndromeJohnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 1 Terminated10 enrolled